Found 6 matching trials
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
PHASE3The purpose of this study is to determine the efficacy of SPD503 compared t...
Location
Multiple Locations
SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms
PHASE3To assess efficacy and safety of SPD503(guanfacine hydrochloride) in subjec...
Location
HOPE Research Institute
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
PHASE4The main aim of this study is learn more about long-term TAK-503 treatment ...
Location
Harmonex Neuroscience Research
Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17
PHASE3The purpose of this study is to assess the safety and efficacy of SPD503 (G...
Location
Multiple Locations
A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy Volunteers
PHASE1This is a drug-drug interaction study; the purpose of this study is to exam...
Location
Advanced Biomedical Research, Inc.
Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe
PHASE3For subjects in Europe that have already participated in either Study SPD50...
Location
Medizinische Universitat Graz Univ fur Kinder